510(k) Report

FDA applicant

Pharmacia Diagnostics, Inc.

Columbia, MD10 decisions1990–20063 recalls

FDA records 10 decisions for Pharmacia Diagnostics, Inc. (Columbia, MD) from 1990 to 2006: 10 510(k) clearances. Most are in product codes LGD (Enzyme Linked Immunoabsorbent Assay…) and LFX (Enzyme Linked Immunoabsorbent Assay, Rubella). Its devices cite 2 predicates, 0 of them its own earlier devices. 3 recalls are linked to its devices.

FDA’s records also spell it “Pharmacia Diagnostics AB”, “Pharmacia Diagnostics GmbH & Co. KG”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, microbiology panel, where it files most

How often FDA has decided Pharmacia Diagnostics, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Pharmacia Diagnostics, Inc. since 2007.

Recalls per year

1in 2019

2017: 22019: 1
2007high 2 (2017) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Pharmacia Diagnostics, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Pharmacia Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Pharmacia”

FDA records each applicant name separately; these may or may not be the same firm.